Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India

• Published in: PLoS neglected tropical diseases Vol. 12; no. 8; p. e0006657
• Main Authors: Mishra, Akhilesh C, Arankalle, Vidya A, Gadhave, Swapnil A, Mahadik, Pritam H, Shrivastava, Shubham, Bhutkar, Mandar, Vaidya, Varsha M
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01-08-2018; Public Library of Science (PLoS)
• Subjects: Adolescent; Adult; Adults; Age; Age groups; Aged; Aged, 80 and over; Antibodies; Antibodies, Neutralizing - blood; Antibodies, Viral - blood; Biology and Life Sciences; Child; Child, Preschool; Clinical trials; Cross-Sectional Studies; Dengue; Dengue - epidemiology; Dengue fever; Dengue Virus - immunology; Detection; Disease; Disease control; Distribution; ELISA; Enzyme-Linked Immunosorbent Assay; Female; Health surveillance; Heterogeneity; Human diseases; Humans; Immunity; Immunity (Disease); Immunoglobulin G; Immunoglobulin G - blood; India - epidemiology; Infant; Infections; Male; Medicine and Health Sciences; Middle Aged; Neutralizing; Parameter estimation; Patchiness; People and Places; Public health; Public health administration; Research and Analysis Methods; Samples; Secondary infection; Seroepidemiologic Studies; Serotypes; Serum; Smart cities; Spatial heterogeneity; Transmission; Tropical diseases; Urbanization; Vaccines; Vector-borne diseases; Viral diseases; Viruses; Young Adult; India; Brazil; Mumbai India; Singapore; Thailand
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0006657

In India, dengue disease is emerging as the most important vector borne public health problem due to rapid and unplanned urbanization, high human density and week management of the disease. Clinical cases are grossly underreported and not much information is available on prevalence and incidence of the disease.
A cross sectional, stratified, facility based, multistage cluster sampling was conducted between May 4 and June 27, 2017 in Pune city. A total of 1,434 participants were enrolled. The serum samples were tested for detection of historical dengue IgG antibodies by ELISA using the commercial Panbio Dengue IgG Indirect ELISA kit. Anti-dengue IgG-capture Panbio ELISA was used for detection of high titered antibodies to detect recent secondary infection. We used this data to estimate key transmission parameters like force of infection and basic reproductive number. A subset of 120 indirect ELISA positive samples was also tested for Plaque Reduction Neutralizing Antibodies for determining serotype-specific prevalence.
Overall, 81% participants were infected with dengue virus (DENV) at least once if not more. The positivity was significantly different in different age groups. All the adults above 70 years were positive for DENV antibodies. Over 69% participants were positive for neutralizing antibodies against all 4 serotypes suggesting intense transmission of all DENV serotypes in Pune. Age-specific seroprevalence was consistent with long-term, endemic circulation of DENV. There was an increasing trend with age, from 21.6% among <36 months to 59.4% in age group 10-12 years. We estimate that 8.68% of the susceptible population gets infected by DENV each year resulting into more than 3,00,000 infections and about 47,000 to 59,000 cases per year. This transmission intensity is similar to that reported from other known hyper-endemic settings in Southeast Asia and the Americas but significantly lower than report from Chennai.
Our study suggests that Pune city has high disease burden, all 4 serotypes are circulating, significant spatial heterogeneity in seroprevalence and suboptimal immunity in younger age groups. This would allow informed decisions to be made on management of dengue and introduction of upcoming dengue vaccines in the city.